Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: A qualitative study

BMC Family Practice

Volumn 12, Issue , 2011, Pages

  Gale, Nicola K ^a   Greenfield, Sheila ^a   Gill, Paramjit ^a   Gutridge, Kerry ^b   Marshall, Tom ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Canynge Hall   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; FEMALE; GENERAL PRACTICE; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUALITATIVE RESEARCH; RISK FACTOR;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; CHEMOPREVENTION; FEMALE; GENERAL PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUALITATIVE RESEARCH; RISK FACTORS;

EID: 79959486794     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-12-59     Document Type: Article

References (54)

1. Primary Prevention of Cardiovascular Diseases With Statin Therapy: A Meta-analysis of Randomized Controlled Trials. P Thavendiranathan A Bagai M Brookhart N Choudhry, Archives of Internal Medicine 2006 166 2307 2313 10.1001/archinte.166.21.2307 17130382 (Pubitemid 44833354)
2. Blood cholesterol and vascular mortality by age, sex and blood pressure: a meta-analysis of individual data from 61 propsective studies with 55000 vascular deaths. Prospective Studies Collaboration, Lancet 2007 370 1829 1839 18061058
3. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. M Law J Morris N Wald, British Medical Journal 2009 338 1665 10.1136/bmj.b1665
4. Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey. N Steel, British Medical Journal 2000 320 1446 1447 10.1136/bmj.320.7247.1446 10827049 (Pubitemid 30311676)
5. A survey of clinician attitudes and management practices in hypertension. F McAlister A Laupacis K Teo P Hamilton T Montague, Journal of Human Hypertension 1997 11 413 419 10.1038/sj.jhh.1000457 9283056 (Pubitemid 27389170)
6. Are preventative drugs enough? A study of patients' expectation of benefit from preventative drugs. P Trewby A Reddy C Trewby V Ashton G Brennan J Inglis, Clinical Medicine-Journal of the Royal College of Physicians of London 2002 2 527 533 (Pubitemid 35477318)
7. Who decides when to start preventative treatment? A questionnaire survey to compare the views of different population subgroups. DK Lewis S Barton, Journal of Epidemiology and Community Health 2003 57 241 242 10.1136/jech.57.4.241 12646536 (Pubitemid 36399109)
8. Predictors of patient preferences for treatments to prevent heart disease. S Bryan P Gill S Greenfield K Gutridge T Marshall, Heart 2006 92 1651 1655 10.1136/hrt.2005.072405 16709699 (Pubitemid 44629179)
9. Resisting medicines: a synthesis of qualitative studies of medicine taking. P Pound N Britten M Morgan L Yardley C Pope G Daker-White, et al. Social Science & Medicine 2005 61 133 155 10.1016/j.socscimed.2004.11.063 21710423 (Pubitemid 40545066)
10. The use of lipid lowering drugs across ethnic groups in the secondary prevention of ischaemic heart disease: analysis of cross sectional surveys in England. PS Gill T Quirke J Mant T Allan, British Journal of General Practice 2004 54 442 443 15186566 (Pubitemid 38771891)
11. Prescribing patterns in high-need Health Authority populations: How does an ethnically mixed composition affect volume and cost? M Hann J Cantrill D Baker P Gill, Journal of Clinical Pharmacy and Therapeutics 2004 29 537 546 10.1111/j.1365-2710.2004.00604.x 15584942 (Pubitemid 40007081)
12. Prescribing of lipid lowering drugs to South Asian patients: an ecological study. M Patel D Wright P Gill D Jerwood J Silcock H Chrystyn, British Medical Journal 2002 325 25 26 10.1136/bmj.325.7354.25 12098726 (Pubitemid 34747938)
13. Hypertension: management of hypertension in adults in primary care. NICE, NICE Clinical Guidelines 2006 G34
14. JBS2: Joint British Societies' Guidelines on Prevention of Cardiovascular Disease in Clinical Practice. D Wood, Heart 2005 91 2244
15. C Bond, Concordance: a partnership in medicine-taking Pharmaceutical Press 2004
16. GMC, Consent: patients and doctors making decisions together 2009
17. MRC/BHF Heart Protection Study of Cholesterol Lowering with Simvastatin in 20.536 high-risk individuals: a randomised placebo-controlled trial. Heart Protection Study Collaborative Group, Lancet 2002 360 9326 7 22 12114036
18. Patients' ideas about medicines: a qualitative study in a general practice population. N Britten, British Journal of General Practice 1994 44 465 468 7748635 (Pubitemid 24317938)
19. Increased absenteeism from work among aware and treated hypertensive and hypercholesterolaemic patients. F Leynen G De Backer E Pelfrene E Clays F Kittel M Moreau, et al. European Journal of Cardiovascular Prevention & Rehabiliation 2006 13 2 261 267 10.1097/01.hjr.0000194420.62379.de 21672932 (Pubitemid 44097733)
20. Labelling in hypertension: a review of the behavioural and psychological consequences. L Macdonald D Sackett R Haynes D Taylor, Journal of Chronic Diseases 1984 37 12 933 942 10.1016/0021-9681(84)90070-5 6396317 (Pubitemid 15153993)
21. The diagnosis of hypertension-psychosocial consequences. A literature review of blood pressure examinations. S Naess J Holmen T Moum T Sorensen, Tidsskr Nor Laegeforen 1992 112 1 24 26 1553638
22. Patient's preferences shed light on the murky world of guidelines-based medicine. J Penston, Journal of Evaluation in Clinical Practice 2007 13 154 159 10.1111/j.1365-2753.2006.00701.x 17286739 (Pubitemid 46238811)
23. Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango). C Charles A Gafni T Whelan, Social Science & Medicine 1997 44 5 681 692 10.1016/S0277-9536(96)00221-3 21710423 (Pubitemid 27067502)
24. C Hogg, Patient, Power and Politics: From Patients to Citizens London: Sage 1999
25. Shared decision-making in primary care: the neglected second half of the consultation. G Elwyn A Edwards P Kinnersley, British Journal of General Practice 1999 49 477 482 10562751 (Pubitemid 29304150)
26. Shared decision making and the concept of equipoise: the competencies of involving patients in healthcare choices. G Elwyn A Edwards P Kinnersley R Grol, British Journal of General Practice 2000 50 892 897 11141876
27. Framework for teaching and learning informed shared decision making. A Towle W Godolphin, British Medical Journal 1999 319 766 771 10488010 (Pubitemid 29431536)
28. Doctor-patient negotiatiom and other social science strategies in patient care. W Katon A Kleinman, The relevance of social science for medicine: culture, illness and healing The Netherlands: Kluwer, Eisenberg L, Kleinman A, 1981
29. The myth of agency and patient choice in health care? The case of drug treatments to prevent coronory disease. S Bryan P Gill S Greenfield K Gutridge T Marshall, Social Science & Medicine 2006 63 2698 2701 10.1016/j.socscimed. 2006.07.008 21710423 (Pubitemid 44485283)
30. Factors influencing clinician's decisions to prescribe medicatioon to prevent coronory heart disease. S Greenfield S Bryan P Gill K Gutridge T Marshall, Journal of Clinical Pharmacy and Therapeutics 2005 30 77 84 10.1111/j.1365-2710.2004.00615.x 15659007 (Pubitemid 41602095)
31. Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study. T Marshall A Rouse, British Medical Journal 2002 325 197 199 10.1136/bmj.325.7357.197 12142309 (Pubitemid 34827893)
32. Letter: Primary prevention strategies for cardiovascular disease in people aged 30 to 74. T Marshall A Rouse, British Medical Journal 2002 325 969 10.1136/bmj.325.7370.969 12399359
33. Joint British Recommendations on prevention of coronary heart disease in clinical practice. D Wood P Durrington N Poulter G McInnes A Rees R Wray, Heart 1998 80 Supplement 2 1 29 10193438
34. Decision aids for people facing health treatment or screening decisions. AM O'Connor CL Bennett D Stacey M BArry NF Col KB Eden, et al. Cochrane Database of Systematic Reviews 2009 3
35. Predictors of patients' preferences for treatments to prevent heart disease. T Marshall S Bryan P Gill S Greenfield K Gutridge, Heart 2006 92 1651 1655 10.1136/hrt.2005.072405 16709699 (Pubitemid 44629179)
36. Lay epidemiology and the prevention paradox: the implications of coronary candidacy for health education. C Davison G Davey Smith S Frankel, Sociology of Health and Illness 1991 13 1 1 19
37. Views and Reviews: The Treatment Paradox. D Spence, British Medical Journal 2008 336 100
38. Letter: Reasons to be cautious about cholesterol lowering. A Cox, British Medical Journal 2008
39. Letter: More reasons to be cautious with statins and other such. A Bamji, British Medical Journal 2008
40. Caution in use of statins in the 'elderly'. T Bell, British Medical Journal 2008
41. Letter: Statins-'treating to target' benefits neither patient nor clinician. D Mackenzie, British Medical Journal 2008
42. Letter: Statins and Targets. J Grant, British Medical Journal 2008
43. Strategies for prescribing statins: evidence does NOT support prescribing a standard dose without further testing or dose adjustment. M Murphy, British Medical Journal 2008
44. L Payer, Disease-Mongers: How Doctors, Drug Companies, and Insurers Are Making You Feel Sick New York: John Wiley and Sons, Inc. 1992
45. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. ATA Collaboration, Lancet 2009 373 1849 1860 10.1016/S0140-6736(09) 60503-1 19482214
46. Multiple risk factor interventions for primary prevention of coronary heart disease. S Ebrahim A Beswick M Burke G Davey Smith, Cochrane Database of Systematic Reviews 2006 4 D001561
47. Measured enthusiasm: does the method of reporting trail results alter perceptions of therapeutic effectiveness? CD Naylor E Chen B Strauss, Annals of Internal Medicine 1992 117 11 916 921 1443954
48. Completeness of reporting trial results: effect on physicians' willingness to prescribe. M Bobbio B Demichelis G Giustetto, Lancet 1994 343 8907
49. Same information, different decisions: the influences of the evidence on the management of hypertension in the elderly. M Cranney T Walley, British Journal of General Practice 1996 46 412 661 663 8978112 (Pubitemid 26388410)
50. Explaining risks: turning numerical data into meaningful pictures. A Edwards G Elwyn A Mulley, British Medical Journal 2002 324 827 10.1136/bmj.324.7341.827 11934777
51. Why do women consent to surgery, even when they do not want to? An interactionist and Bourdieusian analysis. M Dixon-Woods SJ Williams CJ Jackson A Akkad S Kenyon M Habiba, Social Science and Medicine 2006 62 2742 2753 10.1016/j.socscimed.2005.11.006 16343723
52. Doctor-patient communication about drugs: the evidence for shared decision making. FA Stevenson CA Barry N Britten N Barber CP Bradley, Social Science & Medicine 2000 50 829 840 10.1016/S0277-9536(99)00376-7 21710423 (Pubitemid 30058265)
53. Misunderstandings in prescribing decisions in general practice: qualitative study. N Britten FA Stevenson CA Barry N Barber CP Bradley, British Medical Journal 2000 320 484 488 10.1136/bmj.320.7233.484 10678863 (Pubitemid 30173122)
54. Systematic review of randomised controlled trials of inteventions to assist patients to follow prescriptions for medications. RB Haynes KA McKibbon R Kanani, Lancet 1996 348 9024 383 386 10.1016/S0140-6736(96)01073-2 8709739 (Pubitemid 26261515)